Laura Bonapace

1.5k total citations · 1 hit paper
10 papers, 1.2k citations indexed

About

Laura Bonapace is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Laura Bonapace has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Laura Bonapace's work include Cell death mechanisms and regulation (3 papers), Autophagy in Disease and Therapy (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Laura Bonapace is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Autophagy in Disease and Therapy (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Laura Bonapace collaborates with scholars based in Switzerland, Germany and Italy. Laura Bonapace's co-authors include Mohamed Bentires‐Alj, Tobias Junt, Marie‐May Coissieux, Jeffrey Wyckoff, Kirsten D. Mertz, Zsuzsanna Varga, Beat Bornhäuser, Felix Niggli, Jean‐Pierre Bourquin and Martin Schrappe and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Blood.

In The Last Decade

Laura Bonapace

10 papers receiving 1.2k citations

Hit Papers

Cessation of CCL2 inhibition accelerates breast cancer me... 2014 2026 2018 2022 2014 100 200 300 400 500

Peers

Laura Bonapace
Scott H. Olejniczak United States
Andrea Todisco United States
Kurosh Ameri United States
Ana de Vera Switzerland
Scott H. Olejniczak United States
Laura Bonapace
Citations per year, relative to Laura Bonapace Laura Bonapace (= 1×) peers Scott H. Olejniczak

Countries citing papers authored by Laura Bonapace

Since Specialization
Citations

This map shows the geographic impact of Laura Bonapace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Bonapace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Bonapace more than expected).

Fields of papers citing papers by Laura Bonapace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Bonapace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Bonapace. The network helps show where Laura Bonapace may publish in the future.

Co-authorship network of co-authors of Laura Bonapace

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Bonapace. A scholar is included among the top collaborators of Laura Bonapace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Bonapace. Laura Bonapace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ramos, Pedro Marques, Priska Auf der Maur, Atul Sethi, et al.. (2021). The NFIB‐ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells. EMBO Molecular Medicine. 13(4). e13162–e13162. 33 indexed citations
2.
Rössle, Matthias, Gieri Cathomas, Laura Bonapace, et al.. (2016). Interleukin-33 Expression Indicates a Favorable Prognosis in Malignant Salivary Gland Tumors. International Journal of Surgical Pathology. 24(5). 394–400. 18 indexed citations
3.
Смирнова, Т. А., Laura Bonapace, Gwen MacDonald, et al.. (2016). Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages. Oncotarget. 7(50). 82289–82304. 29 indexed citations
4.
Bonapace, Laura, Marie‐May Coissieux, Jeffrey Wyckoff, et al.. (2014). Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature. 515(7525). 130–133. 555 indexed citations breakdown →
5.
Bonapace, Laura, Jeffrey Wyckoff, Thomas G. Oertner, et al.. (2012). If You Don’t Look, You Won’t See: Intravital Multiphoton Imaging of Primary and Metastatic Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 17(2). 125–129. 16 indexed citations
6.
Schmitz, Maike, Petra Breithaupt, Gunnar Cario, et al.. (2011). Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood. 118(7). 1854–1864. 58 indexed citations
7.
Bonapace, Laura, Beat Bornhäuser, Maike Schmitz, et al.. (2010). Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. Journal of Clinical Investigation. 120(4). 1310–1323. 253 indexed citations
8.
Contestabile, Andrea, Tatiana Fila, Claudio Ceccarelli, et al.. (2007). Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with down syndrome and in Ts65Dn mice. Hippocampus. 17(8). 665–678. 221 indexed citations
9.
Bornhäuser, Beat, Laura Bonapace, Dan Lindholm, et al.. (2007). Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway. Blood. 110(6). 2084–2091. 51 indexed citations
10.
Bonapace, Laura, Beat Bornhäuser, Gunnar Cario, et al.. (2007). The BH3-Mimetic Obatoclax Restores the Response to Dexamethasone in Glucocorticoid-Resistant ALL through Induction of Autophagy.. Blood. 110(11). 806–806. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026